To Evaluate the Safety, Tolerability and Efficacy in Male and Female with AGA Treated with HMI-115 Over a 24-week Treatment Period
Clinical trial NCT05324293 · COMPLETED
Trial details
- NCT number
- NCT05324293
- Sponsor
- Hope Medicine (Nanjing) Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-11
- Primary completion
- 2023-09-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.